DaVita Inc. Common Stock (DVA)

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other phys…

Sector

Health Care

Industry

Misc Health and Biotechnology Services

Employees

78,000

Website

www.davita.com/

Fundamentals

1-day range

$178.8$182.53

Market cap

$15.00B

P/E (trailing)

13.64

P/E (forward)

10.47

EPS (trailing)

$12.21

Dividend yield

—

Beta

0.80

Avg. volume

851.0K

Forecasts

7 analyst ratings

DaVita Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• DVA

  DaVita Inc. Common Stock

  $180.7

  ▲ 1.02%
  Market cap $15.00BP/E 13.64
  $101$247.49
• FMS

  Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

  $23.07

  ▼ 0.86%
  Market cap $14.11BP/E 11.62
  $34.57$47.86
• SHC

  Sotera Health Company Common Stock

  $19.27

  ▼ 1.08%
  Market cap $5.13BP/E 46.08
  $13.09$19.85
• VMD

  Viemed Healthcare Inc. Common Shares

  $8.84

  ▼ 1.89%
  Market cap $448.16MP/E 24.70
  $6.05$12.61
• NIVF

  NewGenIvf Group Limited Class A Ordinary Shares

  $0.4085

  ▼ 12.71%
  Market cap $3.85MP/E 0.33
  $0.4509$2,052

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Berkshire Hathaway Cut Capital One Stake by 58% in Q2 — Billionaire Dan Loeb Is Doing the Exact Opposite
  Benzinga · 8/28/2026
• DaVita Enters Value-Based Care Agreement With Humana Medicare Advantage To Provide Care To Members With Chronic Kidney Disease Stages 3B–5
  benzinga · 8/25/2026
• DaVita Enters Value-Based Care Agreement With Humana Medicare Advantage To Provide Care To Members With Chronic Kidney Disease Stages 3B–5
  Benzinga · 8/25/2026
• Forever Committed to Excellence in Care: DaVita Community Care Report 2025
  Yahoo · 8/18/2026
• Berkshire ups Alphabet stake under Greg Abel, making it a top-3 holding
  Yahoo · 8/14/2026
• Tracking Berkshire Hathaway Portfolio - Q2 2026 Update
  SeekingAlpha · 8/14/2026
• Berkshire Hathaway Doubles Down on Homebuilders, Makes Alphabet Top 3 Holding
  Benzinga · 8/14/2026
• Strengthening the Transplant System: 5 Common Myths About Living Kidney Donation
  Yahoo · 8/14/2026
• The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call
  Yahoo · 8/13/2026

• BERKSHIRE HATHAWAY INC · July 31, 2026 · Sale

  183.0K @ $199.55
• Javier Rodriguez · June 16, 2026 · Sale

  39.4K @ $209.28
• Kathleen Alyce Waters · June 15, 2026 · Sale

  6.5K @ $209.17
• Kathleen Alyce Waters · June 15, 2026 · Sale

  8.9K @ $207.84
• Javier Rodriguez · June 15, 2026 · Sale

  30.0K @ $209.5
• Phyllis R. Yale · May 26, 2026 · Gift

  5.0K
• Dennis W. Pullin · May 15, 2026 · Grant

  250
• Gregory J. Moore · May 15, 2026 · Grant

  250
• James O. Hearty · May 15, 2026 · Sale

  15.0K @ $193.98
• Jason M. Hollar · May 15, 2026 · Grant

  250
• Pamela M. Arway · May 15, 2026 · Grant

  250
• Adam H. Schechter · May 15, 2026 · Grant

  250
• Wendy Lee Schoppert · May 15, 2026 · Grant

  250
• Phyllis R. Yale · May 15, 2026 · Grant

  250
• Barbara J. Desoer · May 15, 2026 · Grant

  250

Institutional Ownership

March 31, 2026

Total shares held

61.29M

Total value held

$9.05B

Institutional holders

571